Janette K Burgess Selected Research

Janette K Burgess Research Topics

Disease

53	Asthma (Bronchial Asthma) 12/2021 - 10/2002
21	Inflammation (Inflammations) 01/2021 - 02/2005
16	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 01/2007
14	Airway Remodeling 01/2018 - 04/2004
13	Fibrosis (Cirrhosis) 01/2022 - 01/2013
11	Lung Diseases (Lung Disease) 01/2022 - 01/2012
7	Idiopathic Pulmonary Fibrosis 01/2021 - 04/2015
4	Infections 01/2016 - 02/2011
4	Respiratory Hypersensitivity 02/2012 - 06/2009
3	Emphysema 01/2022 - 01/2021
3	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2020 - 04/2015
3	Hyperplasia 09/2008 - 04/2004
2	Cystic Fibrosis (Mucoviscidosis) 01/2022 - 01/2010
2	Mitochondrial Diseases (Mitochondrial Disease) 11/2021 - 12/2018
1	COVID-19 01/2022
1	Virus Diseases (Viral Diseases) 01/2022
1	Obstructive Lung Diseases (Obstructive Lung Disease) 12/2021
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Chronic Bronchitis 01/2020
1	Iron Overload 01/2020
1	Necrosis 12/2017
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2015

Drug/Important Bio-Agent (IBA)

18	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2003
12	CollagenIBA 04/2020 - 08/2006
11	CytokinesIBA 01/2021 - 02/2005
7	Extracellular Matrix ProteinsIBA 12/2021 - 04/2004
7	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2019 - 11/2005
7	Fibronectins (Fibronectin)IBA 06/2016 - 08/2006
5	SmokeIBA 01/2022 - 01/2012
5	Interleukin-13IBA 01/2021 - 02/2005
5	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021 - 05/2006
5	perlecanIBA 04/2015 - 02/2011
5	Transforming Growth Factor beta (TGF-beta)IBA 01/2013 - 01/2003
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 10/2014
4	InterleukinsIBA 01/2021 - 08/2006
4	type IV collagen alpha3 chain (Goodpasture antigen)IBA 11/2018 - 01/2010
4	Connective Tissue Growth FactorIBA 01/2018 - 01/2003
4	Interleukin-6 (Interleukin 6)IBA 08/2012 - 08/2004
3	Messenger RNA (mRNA)IBA 01/2021 - 01/2003
3	Phosphodiesterase 4 InhibitorsIBA 01/2020 - 09/2006
3	SteroidsIBA 01/2018 - 01/2015
3	Poly I-CIBA 01/2016 - 02/2011
3	Imiquimod (Aldara)FDA LinkGeneric 01/2016 - 02/2011
3	Budesonide (Pulmicort)FDA LinkGeneric 10/2012 - 01/2012
3	GlucocorticoidsIBA 10/2012 - 10/2002
3	Formoterol Fumarate (Oxis)FDA Link 10/2012 - 01/2012
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2011 - 01/2007
3	IntegrinsIBA 04/2008 - 09/2003
2	DNA (Deoxyribonucleic Acid)IBA 11/2021 - 12/2018
2	ElementsIBA 01/2021 - 12/2016
2	PeriostinIBA 01/2021 - 06/2016
2	Pharmaceutical PreparationsIBA 01/2021 - 11/2018
2	RoflumilastIBA 01/2020 - 09/2006
2	Bleomycin (Blenoxane)FDA LinkGeneric 01/2020 - 01/2019
2	Biological ProductsIBA 01/2019 - 10/2010
2	Fibrillar CollagensIBA 12/2017 - 11/2017
2	Oxidoreductases (Dehydrogenase)IBA 12/2017 - 11/2017
2	ChemokinesIBA 06/2016 - 11/2010
2	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2016 - 02/2011
2	Peptides (Polypeptides)IBA 04/2015 - 01/2014
2	ElastinIBA 10/2013 - 04/2012
2	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2013 - 08/2010
2	Protein Isoforms (Isoforms)IBA 08/2012 - 05/2011
2	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2012 - 02/2010
2	Interleukin-8 (Interleukin 8)IBA 01/2012 - 11/2010
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 05/2011 - 09/2008
2	CCAAT-Enhancer-Binding Protein-alphaIBA 01/2007 - 08/2004
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2006 - 02/2005
1	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 01/2022
1	RutheniumIBA 01/2022
1	ProteomeIBA 01/2022
1	HydrogelsIBA 01/2022
1	Mitochondrial DNA (mtDNA)IBA 11/2021
1	Adenosine Monophosphate (AMP)IBA 11/2021
1	Adenine FDA LinkGeneric 11/2021
1	GuanineIBA 11/2021
1	DecorinIBA 01/2021
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2021
1	MucinsIBA 01/2021
1	Differentiation AntigensIBA 01/2021
1	Interleukin-11 (Interleukin 11)IBA 01/2021
1	Deferoxamine (Desferal)FDA LinkGeneric 01/2020
1	Chelating AgentsIBA 01/2020
1	Complex MixturesIBA 01/2020
1	IronIBA 01/2020
1	Transferrin Receptors (Transferrin Receptor)IBA 01/2020
1	SphingosineIBA 01/2020
1	indium-bleomycinIBA 01/2020
1	Mechanistic Target of Rapamycin Complex 1IBA 12/2018
1	Superoxides (Superoxide)IBA 12/2018
1	Interleukin-5 (Interleukin 5)IBA 12/2017
1	Interleukin-33IBA 12/2017
1	TenascinIBA 06/2016
1	N-Formylmethionine Leucyl-PhenylalanineIBA 01/2016
1	LipopolysaccharidesIBA 01/2016
1	Glycoproteins (Glycoprotein)IBA 10/2014

Therapy/Procedure

18	Therapeutics 01/2022 - 03/2004
3	Airway Management 02/2012 - 09/2008
1	Pneumonectomy (Lung Volume Reduction) 12/2021
1	Tissue Scaffolds 01/2021